AbCellera Biologics Inc - ABCL - stock price prediction, stock price target, analyst ratings from 8 analysts

AbCellera Biologics Inc has a share price target of US$ 10, revenue growth forecast of 25.1%, and profit growth estimate of -18.9% for FY25, based on top 8 analyst calls.